SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-18-001172
Filing Date
2018-02-27
Accepted
2018-02-27 16:16:35
Documents
102
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20171231x10k.htm 10-K 4042457
2 EX-12.1 clvs-20171231ex1212dd759.htm EX-12.1 156168
3 EX-23.1 clvs-20171231ex231509864.htm EX-23.1 5351
4 EX-31.1 clvs-20171231ex3111fe53e.htm EX-31.1 19909
5 EX-31.2 clvs-20171231ex3126aa7a0.htm EX-31.2 20149
6 EX-32.1 clvs-20171231ex32156c0fa.htm EX-32.1 8007
7 EX-32.2 clvs-20171231ex3222b5bda.htm EX-32.2 8393
8 GRAPHIC clvs20171231x10k001.jpg GRAPHIC 178422
9 GRAPHIC clvs20171231x10k002.jpg GRAPHIC 109498
  Complete submission text file 0001558370-18-001172.txt   14040537

Data Files

Seq Description Document Type Size
10 EX-101.INS clvs-20171231.xml EX-101.INS 3102003
11 EX-101.SCH clvs-20171231.xsd EX-101.SCH 70714
12 EX-101.CAL clvs-20171231_cal.xml EX-101.CAL 93425
13 EX-101.DEF clvs-20171231_def.xml EX-101.DEF 243837
14 EX-101.LAB clvs-20171231_lab.xml EX-101.LAB 694086
15 EX-101.PRE clvs-20171231_pre.xml EX-101.PRE 516185
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 18645300
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences